A Study of Ciltacabtagene Autoleucel (Cilta-Cel) in People With Newly Diagnosed Multiple Myeloma

Full Title

A Phase 2 Multicohort Trial to Further Characterize the Efficacy and Safety of Ciltacabtagene Autoleucel - CARTITUDE-10

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Maximilian Merz’s office at 646-608-3713.

Protocol
26-047
Phase
Phase II (phase 2)
Disease Status
Newly Diagnosed
Investigator
Maximilian Merz
Co-Investigators
Saad Z. Usmani
Diseases
Hematology › Multiple Myeloma
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07149857
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description